Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.

A study was conducted to determine the clinical efficacy of GLP-1RAs for secondary prevention of atrial fibrillation and ...

Pain complaints among hospitalized patients with COVID-19 were negatively correlated with emergency intubation.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Modifiable, nonclinical risk factors such as lifestyle modifications and physical measures may reduce the risk for sudden cardiac arrest.

Maternal mortality rates in the US remain high, especially compared with those of similarly wealthy countries, despite ...

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya Aminorroaya, MD, MPH.

A scientific statement regarding risk-based primary prevention of heart failure has been published by the American Heart Association.

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including SGLT2is and GLP-1 RAs.

The FDA has approved Rinvoq (upadacitinib), a Janus kinase inhibitor, for the treatment of adults with giant cell arteritis.

Sodium-glucose cotransporter 2 inhibitor use is an independent risk factor for falls in people with type 2 diabetes.